Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Stock prices of pharmacy chains and drug companies took a double hit Thursday afternoon as President Trump announced a "national public health emergency" for the opioid crisis and the St. Louis Post-Dispatch reported that Amazon gained approval in several states to be a wholesale drug distributor.
Key takeaways:
- Stocks likely fell in anticipation of a government crackdown on drug distribution companies, but Trump's speech did not contain specifics about federal action against distributors.
- News that Amazon is entering new markets has had the same effect on other industries, such as grocery chains. Amazon's move into pharmacy services was long-anticipated.
- The end-of-day spike in CVS's share price might be explained by a Wall Street Journal report that CVS is considering an acquisition of insurance giant Aetna.